Encompass Health’s (EHC) “Outperform” Rating Reiterated at Royal Bank of Canada

Royal Bank of Canada restated their outperform rating on shares of Encompass Health (NYSE:EHC) in a research note released on Tuesday morning,Benzinga reports. Royal Bank of Canada currently has a $110.00 price objective on the stock.

Several other research analysts have also recently issued reports on the stock. Barclays raised their target price on shares of Encompass Health from $116.00 to $118.00 and gave the stock an “overweight” rating in a report on Friday, February 7th. Truist Financial reissued a “buy” rating and set a $116.00 target price (up previously from $108.00) on shares of Encompass Health in a report on Wednesday, October 30th. KeyCorp raised their target price on shares of Encompass Health from $117.00 to $120.00 and gave the stock an “overweight” rating in a report on Monday. StockNews.com cut shares of Encompass Health from a “buy” rating to a “hold” rating in a report on Friday, February 7th. Finally, William Blair restated an “outperform” rating on shares of Encompass Health in a research report on Friday, February 7th. One equities research analyst has rated the stock with a hold rating, nine have assigned a buy rating and two have given a strong buy rating to the company. According to MarketBeat, the company currently has an average rating of “Buy” and a consensus target price of $107.67.

Encompass Health Trading Up 2.1 %

NYSE EHC opened at $100.10 on Tuesday. The company has a fifty day simple moving average of $96.00 and a two-hundred day simple moving average of $95.46. The stock has a market cap of $10.08 billion, a P/E ratio of 22.44, a P/E/G ratio of 1.18 and a beta of 0.90. Encompass Health has a 12-month low of $72.57 and a 12-month high of $104.55. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.88.

Encompass Health (NYSE:EHC) last posted its quarterly earnings results on Thursday, February 6th. The company reported $1.17 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.05 by $0.12. Encompass Health had a net margin of 8.48% and a return on equity of 18.06%. On average, analysts forecast that Encompass Health will post 4.76 earnings per share for the current year.

Insider Activity

In other news, CAO Andrew L. Price sold 5,042 shares of Encompass Health stock in a transaction dated Thursday, February 13th. The shares were sold at an average price of $98.29, for a total value of $495,578.18. Following the sale, the chief accounting officer now owns 69,164 shares in the company, valued at $6,798,129.56. This trade represents a 6.79 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Company insiders own 2.10% of the company’s stock.

Institutional Trading of Encompass Health

Several institutional investors have recently modified their holdings of the stock. CANADA LIFE ASSURANCE Co grew its position in shares of Encompass Health by 3.1% in the fourth quarter. CANADA LIFE ASSURANCE Co now owns 82,649 shares of the company’s stock valued at $7,627,000 after purchasing an additional 2,515 shares during the period. NewEdge Advisors LLC boosted its position in Encompass Health by 5.3% during the fourth quarter. NewEdge Advisors LLC now owns 8,209 shares of the company’s stock worth $758,000 after acquiring an additional 412 shares during the last quarter. Jump Financial LLC acquired a new position in Encompass Health during the fourth quarter worth about $2,501,000. Icon Advisers Inc. Co. boosted its position in Encompass Health by 23.2% during the fourth quarter. Icon Advisers Inc. Co. now owns 35,840 shares of the company’s stock worth $3,310,000 after acquiring an additional 6,740 shares during the last quarter. Finally, Mariner LLC boosted its position in Encompass Health by 24.6% during the fourth quarter. Mariner LLC now owns 4,251 shares of the company’s stock worth $393,000 after acquiring an additional 838 shares during the last quarter. Institutional investors and hedge funds own 97.25% of the company’s stock.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.